Search for: "Gene Quinn" Results 221 - 240 of 572
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Apr 2021, 9:06 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc. will moderate a panel consisting of Kate Gaudry of Kilpatrick Townsend & Stockton LLP; Ryan Abbott, Professor of Law and Health Sciences at the University of Surrey School of Law, and Adjunct Assistant Professor of Medicine at the David Geffen School of Medicine at UCLA; and Richard Frank of Siemens Healthineers. [read post]
6 Nov 2021, 9:17 pm by Patent Docs
Matthias Schneider of AUDI AG, Mattia Fogliacco of Sisvel Group, Taraneh Maghamé of Via Licensing Corporation, Hasan Rashid of GE, and Gene Quinn of IPWatchdog, Inc. will discuss: • The role of patent pools in the SEP licensing ecosystem • Are patent pools appropriate for non-traditional SEP verticals? [read post]
25 Apr 2021, 9:02 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc. will moderate a panel consisting of Carlo Cotrone of Techtronic Industries North America (TTI) and Jim Durkin of IP.com. [read post]
29 Jan 2017, 9:50 pm by Patent Docs
Gene Quinn of IPWatchdog.com, Kate Gaudry of Kilpatrick, Townsend & Stockton, and Kenneth Corsello of IBM will discuss best practices for software patents and predictions for 2017. [read post]
27 Mar 2021, 8:39 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc. will moderate a panel consisting of Mark Stignani of Barnes & Thornberg, Adam Greyson of HP, and Matt Troyer of Anaqua. [read post]
23 Apr 2022, 8:48 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc.; Stephen Byrn of Purdue University and Improved Pharma; Steven Zeman of Grünecker Patent Attorneys and Attorneys at Law; and Eyal Barash of Barash Law, LLC will focus on questions related to obviousness and inventive step, enablement and written description sufficiency, and scientific aspects of pharmaceutical salts, and address issues related to litigation of patents directed to such salts from both a legal and expert witness point of view. [read post]
13 Jan 2020, 2:15 pm by IPWatchdog
Commenting on the development, IPWatchdog CEO and Founder Gene Quinn tweeted out his view that this was a “bad day for patent eligibility” and that the denial of Athena ultimately “means medical diagnostics are NOT patentable in America. [read post]
22 Aug 2020, 9:15 pm by Patent Docs
Gene Quinn of IPWatchdog.com and William Mansfield of PatentSight® -- A LexisNexis Company will analyze the decision made by Amazon Inc. to "buy" Zoox Inc. [read post]
4 Jul 2020, 9:15 am by Rebecca Tapscott
”  Previous top 25 lists have been written by Gene Quinn,  Bruce Kisliuk,  Russell Slifer, Kent Richardson, and Eileen McDermott. [read post]
9 Feb 2019, 9:50 pm by Patent Docs
Gene Quinn of IPWatchdog and Kevin Noonan of Patent Docs will take a look at the recently announced merger between Bristol-Myers Squibb and Celgene, including what the combined company will look like from a patent perspective, and what competition regulators are likely to be interested in questioning about this acquisition. [read post]
5 Mar 2022, 7:11 pm by Patent Docs
Patent & Trademark Office; John White, CEO of PCT Learning Center; and Gene Quinn of IPWatchdog, Inc. will discuss the most common mistakes made when entering the U.S. national stage through the PCT. [read post]
15 May 2021, 8:43 pm by Patent Docs
David Donoghue of Holland & Knight, Evan McAlpine and Ryan Hynes of Relativity, and Gene Quinn of IPWatchdog, Inc. will discuss the proper balance between defensive monitoring and monitoring to identify white space and other specific examples of how landscaping analysis can be useful to proactively provide value-add to business development strategies, and will also address what to do when litigation is approaching. [read post]
13 Jun 2020, 7:53 pm by Patent Docs
Gene Quinn of IPWatchdog.com, Megan McLoughlin of LexisNexis® IP, and Dr. [read post]
30 Sep 2018, 6:55 am by Steve Brachmann
"That defeats the entire point of a trademark," said Gene Quinn, founder of IPWatchdog.com. [read post]
12 Jun 2021, 8:07 pm by Patent Docs
Brian Arthur Pomper of Akin Gump; Melissa Brand, Assistant General Counsel, IP, Biotechnology Innovation Organization (BIO); Sarbani Chattopadhyay of LexisNexis; and Gene Quinn of IPWatchdog will discuss the petition by South Africa and India at the World Trade Organization (WTO) to waive most of the protections in the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement, and whether this is helping or hurting innovation. [read post]
23 Oct 2021, 9:20 pm by Patent Docs
Independent inventor Gilbert Hyatt; Andrew Grossman of BakerHostetler; Paul Kamenar, Senior Fellow of the Administrative Conference of the United States; and Gene Quinn of IPWatchdog, Inc. will discuss Mr. [read post]
25 Jul 2020, 9:23 pm by Patent Docs
Gene Quinn of IPWatchdog.com and Megan McLoughlin of LexisNexis IP will be joined by Drew Hirshfeld, Commissioner for Patents; Jay Kramer, Group Director Patent Operations; and Matthew Such, Group Director Patent Operations of the U.S. [read post]
16 Jun 2022, 2:15 pm by Eileen McDermott
Writing at the time, IPWatchdog Founder and CEO Gene Quinn said that if the bill were to include a standing requirement “it will fix a lot of the ailments of the IPR system, eliminating most of the gaming. [read post]
17 May 2020, 9:14 am by Patent Docs
Gene Quinn of IPWatchdog.com and Shawn Ambwani of Unified Patents will discuss recent changes to § 314, focusing on General Plastics, NHK Spring, the data, and practice tips around them, and also look to the factors in both petitioner's and patent owner's behavior that the Board is free to consider, analyze policy concerns, and recommend changes. [read post]
28 Nov 2021, 8:50 pm by Patent Docs
Roberta Young of Seyfarth Shaw LLP, Aparna Nemlekar of Fox Rothschild LLP, Megan McLoughlin of LexisNexis Intellectual Property Solutions, and Gene Quinn of IPWatchdog, Inc. will focus on trends in patent eligibility (35 U.S.C. [read post]